-
EP2271618
European procedure
Extract from the Register of European Patents
EP About this file: EP2271618
| EP2271618 - PHARMACEUTICAL COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.03.2015 Database last updated on 21.05.2024 | Most recent event Tooltip | 27.03.2015 | No opposition filed within time limit | published on 29.04.2015 [2015/18] | Applicant(s) | For all designated states Astex Therapeutics Limited 436 Cambridge Science Park Milton Park Cambridge Cambridgeshire CB4 0QA / GB | [2011/02] | Inventor(s) | 01 /
FREDERICKSON, Martyn 436 Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0QA / GB | [2014/21] |
| Former [2011/02] | 01 /
FREDERICKSON, Martyn 436 Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0QA / GB | Representative(s) | Cooke, Richard Spencer Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [2014/21] |
| Former [2011/02] | Cooke, Richard Spencer Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | Application number, filing date | 09731468.6 | 09.04.2009 | [2011/02] | WO2009GB50358 | Priority number, date | GB20080006527 | 11.04.2008 Original published format: GB 0806527 | US20080044256 | 11.04.2008 Original published format: US 44256 | [2011/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009125230 | Date: | 15.10.2009 | Language: | EN | [2009/42] | Type: | A1 Application with search report | No.: | EP2271618 | Date: | 12.01.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.10.2009 takes the place of the publication of the European patent application. | [2011/02] | Type: | B1 Patent specification | No.: | EP2271618 | Date: | 21.05.2014 | Language: | EN | [2014/21] | Search report(s) | International search report - published on: | EP | 15.10.2009 | Classification | IPC: | C07D209/44, A61K31/4035, A61P35/00 | [2011/02] | CPC: |
C07D209/44 (EP,US);
C07D295/155 (US);
A61P35/00 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/02] | Extension states | AL | 27.10.2010 | BA | 27.10.2010 | RS | 27.10.2010 | Title | German: | PHARMAZEUTISCHE VERBINDUNGEN | [2011/02] | English: | PHARMACEUTICAL COMPOUNDS | [2011/02] | French: | COMPOSÉS PHARMACEUTIQUES | [2011/02] | Entry into regional phase | 27.10.2010 | National basic fee paid | 27.10.2010 | Designation fee(s) paid | 27.10.2010 | Examination fee paid | Examination procedure | 14.10.2010 | Amendment by applicant (claims and/or description) | 27.10.2010 | Examination requested [2011/02] | 31.05.2011 | Despatch of a communication from the examining division (Time limit: M06) | 24.01.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 27.03.2012 | Reply to a communication from the examining division | 03.05.2012 | Despatch of a communication from the examining division (Time limit: M06) | 06.11.2012 | Reply to a communication from the examining division | 11.12.2013 | Communication of intention to grant the patent | 08.04.2014 | Fee for grant paid | 08.04.2014 | Fee for publishing/printing paid | 08.04.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 31.05.2011 | Opposition(s) | 24.02.2015 | No opposition filed within time limit [2015/18] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 27.03.2012 | Request for further processing filed | 27.03.2012 | Full payment received (date of receipt of payment) Request granted | 07.05.2012 | Decision despatched | Fees paid | Renewal fee | 12.04.2011 | Renewal fee patent year 03 | 28.03.2012 | Renewal fee patent year 04 | 12.04.2013 | Renewal fee patent year 05 | 25.03.2014 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2006109085 (ASTEX THERAPEUTICS LTD [GB], et al) [A] 1-46 * example 55 ** claim - * | by applicant | US4666828 | US4683202 | US4801531 | US5192659 | US5272057 | US5882864 | WO9929705 | US6218529 | WO2006109085 | WO2006117669 | WO2008044027 | WO2008044029 | WO2008044034 | - GRENERT, J BIOL CHEM., (1997), vol. 272, pages 23834 - 23850 | - KAMAL, NATURE, (2003), vol. 425, pages 407 - 410 | - BRAZIDEC, J. MED. CHEM., (2004), vol. 47, pages 3865 - 3873 | - JOLLY; MORIMOTO, JNCI, (2000), vol. 92, no. 19, pages 1564 - 1572 | - GIANNINI ET AL., MOL CELL BIOL., (2004), vol. 24, no. 13, pages 5667 - 76 | - ROE, CELL, (2004), vol. 116, pages 87 - 98 | - MATHEWS ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (2003), vol. 47, pages 2208 - 2216 | - COWEN; LINDQUIST, SCIENCE, (20050930), vol. 309, no. 5744, pages 2175 - 6 | - COWEN LE; LINDQUIST S., "Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi", SCIENCE, (20050930), vol. 309, no. 5744, pages 2185 - 9 | - DICKEY ET AL., CURR ALZHEIMER RES., (200504), vol. 2, no. 2, pages 231 - 8 | - PAREEK, T.K. ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (2006), vol. 103, pages 791 - 796 | - WANG, CHENG-HAUNG ET AL., ACTA PHARMACOLOGICA SINICA., (2005), vol. 26, pages 46 - 50 | - AMADORO, G, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2006), vol. 103, pages 2892 - 2897 | - CHRISTOPH, T ET AL., NEUROPHARMACOLOGY, (2006), vol. 51, pages 12 - 17 | - RASHIDAN, J. ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (2005), vol. 102, pages 14080 - 14085 | - OSUGA, H. ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (2000), vol. 97, pages 10254 - 10259 | - WEISHAUPT, J. ET AL., MOLECULAR AND CELLULAR NEUROSCIENCE., (2003), vol. 24, pages 489 - 502 | - NAGKAGAWA, S; UMEHARA T; MATSUDA C ET AL., BIOCHEM. BIOPHYS. RES COMMUN., (2007), vol. 353, pages 882 - 888 | - WAXMAN L; WITNEY, M ET AL., PNAS, (2001), vol. 98, pages 13931 - 13935 | - BERNARD TESTA, BIOCHEMICAL PHARMACOLOGY, (2004), vol. 68, pages 2097 - 2106 | - RAUTIO ET AL., NATURE REVIEWS, (200803), vol. 7, pages 255 - 270 | - IGARASHI ET AL., CHEM. PHARM. BULL., (2007), vol. 55, no. 2, pages 328 - 333 | - THORBERG ET AL., J. MED. CHEM., (1987), vol. 30, no. 11, pages 2008 - 2012 | - P. HEINRICH STAHL, CAMILLE G. WERMUTH, Pharmaceutical Salts: Properties, Selection, and Use, HARDCOVER, (200208), page 388 | - BERGE ET AL., "Pharmaceutically Acceptable Salts", J. PHARM. SCI., (1977), vol. 66, pages 1 - 19 | - JERRY MARCH, Advanced Organic Chemistry, 4th Edition, WILEY INTERSCIENCE | - L. W. DEADY, SYN. COMM., (1977), vol. 7, pages 509 - 514 | - CAHN; INGOLD; PRELOG, Advanced Organic Chemistry, 4th Edition,, JOHN WILEY & SONS, (1992), pages 109 - 114 | - CAHN; INGOLD; PRELOG, ANGEW. CHEM. INT. ED. ENGL., (1966), vol. 5, pages 385 - 415 | - TSUGAWA, ONCOLOGY, (1993), vol. 50, page 418 | - GORRE, BLOOD, (2002), vol. 100, pages 3041 - 3044 | - BALI, CANCER RES., (2004), vol. 64, no. 10, pages 3645 - 52 | - BIGNELL, NATURE, (2002), vol. 417, no. 6892, pages 949 - 54 | - MITSIADES, BLOOD, (2006), vol. 107, pages 1092 - 1100 | - SITTLER, HUMAN MOLECULAR GENETICS, (2001), vol. 10, no. 12, pages 1307 - 1315 | - LANARO ET AL., HUMAN MOLECULAR GENETICS, (2001), vol. 10, no. 12, pages 1307 - 1315 | - YEO, BIOCHEM BIOPHYS RES COMMUN., (20031230), vol. 320, no. 3, pages 816 - 24 | - WAX, RHEUMATISM, (2003), vol. 48, no. 2, pages 541 - 550 | - RIGANO ET AL., ANN. N. Y. ACAD. SCI., (2007), vol. 1107, pages 1 - 10 | - SUN; LIAO, ARTERIOSCLER THROMB VASC BIOL., (2004), vol. 24, no. 12, pages 2238 - 44 | - STOELTZING, J NATL CANCER INST, (2004), vol. 96, pages 946 - 956 | - LIN ET., J CELL BIOCHEM., (20041201), vol. 94, no. 1, pages 194 - 201 | - KOBAYASHI, HYPERTENSION, (2004), vol. 44, no. 6, pages 956 - 62 | - YORGIN, J IMMUNOL., (19991215), vol. 164, no. 6, pages 2915 - 23 | - WHITNEY, PROC NATL ACAD SCI USA., (20001220), vol. 98, no. 24, pages 13931 - 5 | - KUMAR, MALAR. J., (20021215), vol. 2, no. 1, page 30 | - JAN, L.Y.; JAN, Y.N., "A Superfamily of Ion Channels", NATURE, (1990), vol. 345, no. 6277, page 672 | - SANGUINETTI, M.C.; JIANG, C.; CURRAN, M.E.; KEATING, M.T., "A Mechanistic Link Between an Inherited and an Acquired Cardiac Arrhythmia: HERG encodes the Ikr potassium channel", CELL, (1995), vol. 81, pages 299 - 307 | - TRUDEAU, M.C.; WARMKE, J.W.; GANETZKY, B.; ROBERTSON, G.A., "HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel Family", SCIENCE, (1995), vol. 269, pages 92 - 95 | - SHEEHAN ET AL., J. AMER. CHEM SOC., (1955), vol. 77, page 1067 | - SHEEHAN ET AL., J. ORG. CHEM., (1961), vol. 26, page 2525 | - CASTRO ET AL., TETRAHEDRON LETTERS, (1990), vol. 31, page 205 | - L. A. CARPINO, J. AMER. CHEM. SOC., (1993), vol. 115, page 4397 | - KONIG ET AL., CHEM.BER, vol. 103, no. 708, pages 2024 - 2034 | - JERRY MARCH, Advanced Organic Chemistry, 4th edition,, WILEY INTERSCIENCE, page 119 | - FIESERS, Reagents for Organic Synthesis, JOHN WILEY, vol. 1-17 | - JEREMIAH P. FREEMAN, Organic Syntheses, JOHN WILEY, vol. 1-8 | - J COMB CHEM., (2004), vol. 6, no. 2, pages 159 - 64 | - LEISTER W; STRAUSS K; WISNOSKI D; ZHAO Z; LINDSLEY C., "Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries", J COMB CHEM., (2003), vol. 5, no. 3, pages 322 - 9 | - R. G. STRICKLY, "Solubilizing Excipients in oral and injectable formulations", PHARMACEUTICAL RESEARCH, (2004), vol. 21, no. 2, pages 201 - 230 | - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY | - ANGERER, METH. ENZYMOL., (1987), vol. 152, page 649 | - "Fluorescence In Situ Hybridization: Technical Overview", JOHN M. S. BARTLETT, Molecular Diagnosis of Cancer, Methods and Protocols, (200403), pages 077 - 088 | - DEPRIMO ET AL., BMC CANCER, (2003), vol. 3, page 3 | - JEZ, J.M. ET AL., CHEM BIOL., (200304), vol. 10, no. 4, pages 361 - 8 | - TURNBULL W.B.; DARANAS A.H., J. AM. CHEM. SOC., (20031203), vol. 125, no. 48, pages 14859 - 66 | - SIGURSKJOLD B.W., ANAL BIOCHEM., (20000115), vol. 277, no. 2, pages 260 - 6 | - NOCIARI, M. M; SHALEV, A.; BENIAS, P.; RUSSO, C., JOURNAL OF IMMUNOLOGICAL METHODS, (1998), vol. 213, pages 157 - 167 |